D'Angelo D - Search Results

1

A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma.

Uboldi S, Calura E, Beltrame L, Fuso Nerini I, Marchini S, Cavalieri D, Erba E, Chiorino G, Ostano P, D'Angelo D, D'Incalci M, Romualdi C. Uboldi S, et al. PLoS One. 2012;7(4):e35423. doi: 10.1371/journal.pone.0035423. Epub 2012 Apr 16. PLoS One. 2012. PMID: 22523595 Free PMC article.

2

The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.

D'Angelo D, Borbone E, Palmieri D, Uboldi S, Esposito F, Frapolli R, Pacelli R, D'Incalci M, Fusco A. D'Angelo D, et al. Eur J Cancer. 2013 Mar;49(5):1142-51. doi: 10.1016/j.ejca.2012.10.014. Epub 2012 Nov 10. Eur J Cancer. 2013. PMID: 23149213

3

MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.

Mussnich P, Rosa R, Bianco R, Fusco A, D'Angelo D. Mussnich P, et al. Expert Opin Ther Targets. 2015;19(8):1017-26. doi: 10.1517/14728222.2015.1057569. Epub 2015 Jun 24. Expert Opin Ther Targets. 2015. PMID: 26107137

4

Mir-23b and miR-130b expression is downregulated in pituitary adenomas.

Leone V, Langella C, D'Angelo D, Mussnich P, Wierinckx A, Terracciano L, Raverot G, Lachuer J, Rotondi S, Jaffrain-Rea ML, Trouillas J, Fusco A. Leone V, et al. Mol Cell Endocrinol. 2014 Jun 5;390(1-2):1-7. doi: 10.1016/j.mce.2014.03.002. Epub 2014 Mar 28. Mol Cell Endocrinol. 2014. PMID: 24681352

5

High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.

D'Angelo D, Mussnich P, Rosa R, Bianco R, Tortora G, Fusco A. D'Angelo D, et al. BMC Cancer. 2014 Nov 20;14:851. doi: 10.1186/1471-2407-14-851. BMC Cancer. 2014. PMID: 25409711 Free PMC article.

6

HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.

Palmieri D, Valentino T, D'Angelo D, De Martino I, Postiglione I, Pacelli R, Croce CM, Fedele M, Fusco A. Palmieri D, et al. Oncogene. 2011 Jul 7;30(27):3024-35. doi: 10.1038/onc.2011.21. Epub 2011 Feb 21. Oncogene. 2011. PMID: 21339738

7

Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

D'Angelo D, Palmieri D, Mussnich P, Roche M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J, Fusco A. D'Angelo D, et al. J Clin Endocrinol Metab. 2012 Jul;97(7):E1128-38. doi: 10.1210/jc.2011-3482. Epub 2012 May 7. J Clin Endocrinol Metab. 2012. PMID: 22564666

8

The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco A. Mussnich P, et al. Mol Oncol. 2013 Jun;7(3):531-42. doi: 10.1016/j.molonc.2013.01.002. Epub 2013 Jan 17. Mol Oncol. 2013. PMID: 23384558 Free PMC article.

9

HMGA1-pseudogene expression is induced in human pituitary tumors.

Esposito F, De Martino M, D'Angelo D, Mussnich P, Raverot G, Jaffrain-Rea ML, Fraggetta F, Trouillas J, Fusco A. Esposito F, et al. Cell Cycle. 2015;14(9):1471-5. doi: 10.1080/15384101.2015.1021520. Cell Cycle. 2015. PMID: 25894544 Free PMC article.

10

Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.

D'Angelo D, Esposito F, Fusco A. D'Angelo D, et al. Front Med (Lausanne). 2015 Jun 8;2:39. doi: 10.3389/fmed.2015.00039. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26137461 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters